Novanta Inc. (NOVT) key performance indicators and operating metrics (14 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Gross Profit Margin (GAAP, Total) | 44.10 percent | FY2026-Q1 |
| Overall Book-to-Bill Ratio | 1.10 ratio | FY2026-Q1 |
| Adjusted Diluted Earnings per Share | 0.81 USD_per_share | FY2026-Q1 |
| Adjusted Operating Income | 43.2M | FY2026-Q1 |
| Adjusted Earnings Before Interest Taxes Depreciation and Amortization | 57.1M | FY2026-Q1 |
| Organic Revenue Growth | 3.10 percent | FY2026-Q1 |
| Revenue (Medical Solutions, GAAP) | 126.46M | FY2026-Q1 |
| Gross Profit Margin (GAAP, Automation Enabling Technologies) | 47.80 percent | FY2026-Q1 |
| Adjusted Gross Profit Margin (Non-GAAP, Automation Enabling Technologies) | 48.70 percent | FY2026-Q1 |
| Adjusted Gross Profit Margin (Non-GAAP, Medical Solutions) | 43.40 percent | FY2026-Q1 |
| Bookings Growth (Year over Year) | 37.00 percent | FY2026-Q1 |
| Gross Profit Margin (GAAP, Medical Solutions) | 41.30 percent | FY2026-Q1 |
| Revenue (Automation Enabling Technologies, GAAP) | 131.24M | FY2026-Q1 |
| Customer Bookings Growth (Year over Year) (Core Businesses) | 25.00 percent | FY2025-Q4 |
Back to NOVT overview · NOVT earnings · NOVT holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.